期刊文献+

恶性胸腔积液中淋巴细胞和树突状细胞的研究进展

原文传递
导出
摘要 恶性胸腔积液是恶性肿瘤晚期常见并发症,预后较差。但其中含有丰富的免疫细胞,可体外诱导培养后应用于肿瘤的免疫治疗。本文对恶性胸腔积液中淋巴细胞和树突状细胞的功能特点、诱导活化方法、在肿瘤生物学治疗方面的临床应用及其前景作了介绍。
出处 《国际呼吸杂志》 2006年第9期663-665,共3页 International Journal of Respiration
  • 相关文献

参考文献17

  • 1Dalbeth NA,Lee YC,Gury B.Lymphocytes in pleural disease.Curr Opin Pulm Med,2005,11(4):334-339.
  • 2Oshikawa K,Yanagisawa K,Ohno S,et al.Expression of ST2 in helper T lymphocytes of malignant pleural effusions.Am J Respir Crit Care Med,2002,165(7):1005-1009.
  • 3Okamoto M,Kawabe T,Iwasaki Y,et al.Evaluation of interferon-[gamma],interferon-[gamma]-inducing cytokines,and interferon-[gamma]-inducible chemokines in tuberculous pleural effusions.J Lab Clin Med,2005,145(2):88-93.
  • 4Melis M,Pace E,Siena L,et al.Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space.Am J Respir Crit Care Med,2003,167(8):1131-1138.
  • 5Chen YM,Tsai CM,Whang-Peng J,et al.Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity:comparison of malignant and tuberculous pleural effusions.J Interferon Cytokine Res,2001,21 (4):249-256.
  • 6Chen YM,Ting CC,Peng JW,et al.Restoration of cytotoxic T lymphocyte function in malignant pleural effusion:interleukin-15 vs.interleukin-2.J Interferon Cytokine Res,2000,20 (1):31-39.
  • 7Kan N.Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432followed by adoptive transfer with cultured effusion lymphocytes.Gan To Kagaku Ryoho,2003,30(11):1559-1561.
  • 8Gjomarkaj M,Pace E,Melis M,et al.Dendritic cells with a potent accessory activity are present in human exudative malignant pleural effusions.Eur Respir J,1997,10(3):592-597.
  • 9Almand B,Resser JR,Lindman B,et al.Clinical significance of defective dendritic cell differentiation in cancer.Clin Cancer Res,2000,6(5):1755-1766
  • 10Katsenelson NS,Shurin GV,Bykovskaia SN,et al.Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function.Mod Pathol,2001,14 (1):40-45.

二级参考文献7

  • 1Gabrilovich DI, Corak J, Ciernik IF, et al. Decrease antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res, 1997, 3:483-490.
  • 2Heinzinger M, Waller CF, von den Berg A, et al. Generation of dendritic cells from patients with chronic myelogenous leukaemia.Ann Hematol, 1999, 78:181-186.
  • 3Hubert P, Greimers R, Franzen-Detrooz E, et al. In vitro propagated dendrtic cells from patients with human-papilloma virus-associated preneoplastic lesions of the uterine cervix: use of Flt3 ligand. Cancer Immunol Immunother, 1998, 47: 81-89.
  • 4Yanagawa H, Takeuchi E, Suzuki Y, et al. Presence and potent immunosuppressive role of interleukin-10 in malignant pleural effusion due to lung cancer. Cancer Lett, 1999, 136:27-32.
  • 5Yanagawa H, Takeuchi E, Suzuki Y. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer.Cancer Immunol Immunother, 1999, 48:396-400.
  • 6Geissmann F, Revy P, Regnault A, et aL TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol,1999, 162:4567-4575.
  • 7Yoshihiro S,Hiroaki Y, Yasuhiko N, et al. Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer. Lung Cancer,2001,34:195-205.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部